Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10962704 | Vaccine | 2016 | 6 Pages |
Abstract
Oral vaccination is a safe, cost effective and non-invasive method suitable for mass immunization. We fabricated nanoparticle (NP) with 14kd polycaprolactone (PCL) entrapping hepatitis B surface antigen (HBsAg) stabilized with Pluronics® F127 and used it as oral delivery vehicle. We evaluated its efficacy for specific antibody production and compared with parenteral routes of immunization in mice. We found a superior antibody response with a higher titer of anti-HBsAg antibody till 2 months following single oral administration compared to other routes of immunization and conventional alum-based HBsAg vaccine. The NPs with the antigen were found in the macrophages in small intestinal villi, peripheral lymph nodes and other reticulo-endothelial organs 2 months after oral administration. This study suggests the efficacy of the current nanocarrier system for efficient antigen presentation disseminated in peripheral lymphoid tissues following oral administration with a prolonged antibody response, which can minimize the requirement of booster dose.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Amit K. Dinda, Madhusudan Bhat, Sandeep Srivastava, Sarat K. Kottarath, Chandravilas K. Prashant,